A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2011
12/27/2011	US8084037 Recombinant parainfluenza virus expression systems and vaccines
12/27/2011	US8084031 Method for the treatment of inflammatory disorders
12/27/2011	US8084028 Antibodies to VLA-1
12/27/2011	US8084015 Immunostimulatory complex of a cationic peptide immunogen and anionic CpG single-stranded DNA oligonucleotide
12/22/2011	WO2011159980A1 Anti-axl antibodies and methods of use
12/22/2011	WO2011159857A1 Carboline carboxamide compounds useful as kinase inhibitors
12/22/2011	WO2011159717A1 Inhibition of pro-inflammatory cytokine induced response
12/22/2011	WO2011159328A1 Methods of treatment using tlr7 and/or tlr9 inhibitors
12/22/2011	WO2011158197A1 New cathepsin s protease inhibitors, useful in the treatment of e.g. autoimmune disorders, allergy and chronic pain conditions
12/22/2011	WO2011157816A1 L. johnsonii la1, b. longum ncc2705 and immune disorders
12/22/2011	WO2011131786A3 Process for preparing an immunoglobulin composition
12/22/2011	WO2011094467A3 Methods of treating diabetes with dll4 antagonists
12/22/2011	WO2011088219A3 Therapeutics and processes for treatment of immune disorders
12/22/2011	WO2008068638A8 Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity
12/22/2011	US20110314575 Plasmodium Vaccines, Antigens, Compositions and Methods
12/22/2011	US20110313229 Therapy Targeting Cancer Stem Cells
12/22/2011	US20110313041 Food supplements on the basis of pantothenic acid
12/22/2011	US20110313031 Olioodeoxynucleotide and its use to induce an immune response
12/22/2011	US20110313016 Treatment of Intestinal Conditions
12/22/2011	US20110313005 Topically applicable pharmaceutical preparation
12/22/2011	US20110313004 Deuterated pyridinones
12/22/2011	US20110313000 Ccr9 inhibitors and methods of use thereof
12/22/2011	US20110312974 Heteroaryl antagonists of prostaglandin d2 receptors
12/22/2011	US20110312963 P38 map kinase inhibitors
12/22/2011	US20110312960 Pyrazine derivatives and use as pi3k inhibitors
12/22/2011	US20110312951 C-Ring Modified Tricyclic Benzonaphthiridinone Protein Kinase Inhibitors and Use Thereof
12/22/2011	US20110312945 Crth2 modulators
12/22/2011	US20110312944 Heterocyclic Compounds Which Modulate The CB2 Receptor
12/22/2011	US20110312940 Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (p13-kinases) inhibitor
12/22/2011	US20110312939 New chemical compounds
12/22/2011	US20110312936 Cyclohexyl-azetidinyl antagonists of ccr2
12/22/2011	US20110312935 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents
12/22/2011	US20110312922 EDTA Resistant S100A12 Complexes (ERAC)
12/22/2011	US20110312920 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
12/22/2011	US20110311652 Novel Saponin Compounds, Methods of Preparation Thereof, Use Thereof and Pharmaceutical Compositions
12/22/2011	US20110311629 Non-adhesive elastic gelatin matrices
12/22/2011	US20110311617 Oral vaccine
12/22/2011	US20110311615 Novel gp41 antigens
12/22/2011	US20110311613 Topical formulations of flap inhibitors for the treatment of dermatological conditions
12/22/2011	US20110311590 Compositions for treating an allergic or asthmatic condition
12/22/2011	US20110311589 Compositions and dosage regimes comprising a clostridial vaccine and levamisole
12/22/2011	US20110311588 Agents and treatment for snoring and respiratory effort related arousals in sleep
12/22/2011	US20110311587 Fusogenic virus-like particles and uses thereof
12/22/2011	US20110311586 Materials and methods for respiratory disease control in canines
12/22/2011	US20110311584 Use of flt3 ligand for enhancing immune responses in rna immunization
12/22/2011	US20110311583 Novel lipids and compositions for the delivery of therapeutics
12/22/2011	US20110311582 Novel lipids and compositions for the delivery of therapeutics
12/22/2011	US20110311581 Reverse genetics of negative-strand rna viruses in yeast
12/22/2011	US20110311580 Settings for recombinant adenoviral-based vaccines
12/22/2011	US20110311579 Flaviviruses expressing the prM, E, and NS1 proteins of other flaviviruses and uses thereof
12/22/2011	US20110311578 Recombinant inactivated viral vector vaccine
12/22/2011	US20110311577 Method of producing a vaccine
12/22/2011	US20110311576 Mixing lyophilised meningococcal vaccines with non-hib vaccines
12/22/2011	US20110311575 MIXING LYOPHILISED MENINGOCOCCAL VACCINES WITH D-T-Pa VACCINES
12/22/2011	US20110311574 Multiple vaccination including serogroup c meningococcus
12/22/2011	US20110311572 Nucleotide and amino acid sequences encoding an exported protein 1 derived from plasmodium vivax and uses thereof
12/22/2011	US20110311570 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
12/22/2011	US20110311569 HIV-1 Peptides, Nucleic Acids, and Compositions and Uses Thereof
12/22/2011	US20110311568 Vaccine
12/22/2011	US20110311567 Immunogenically-Enhanced Polypeptides and Related Methods
12/22/2011	US20110311566 Methods and materials for generating t cells
12/22/2011	US20110311565 Phage Constructs, Sequences and Antigenic Compositions for Immunocontraception of Animals
12/22/2011	US20110311563 Synthetic Antigenic Peptides and Lipopeptides Derived from Mycobacterium Avium Subsp. Paratubuerculosis
12/22/2011	US20110311560 Methods and Compositions Relating to CCR5 Antagonist, IFN-Gamma and IL-13 Induced Inflammation
12/22/2011	US20110311559 Method of identifying cd4+ cd25+ t-cells activated to an antigen which express cd8
12/22/2011	US20110311558 Recombinant Bone Marrow Stromal Antigen-2 in the Treatment of Autoimmune Diseases
12/22/2011	US20110311557 Reciprocal serum/plasma exchange for the treatment of cancer
12/22/2011	US20110311544 Anti-cd71 Monoclonal Antibodies and Uses Thereof for Treating Malignant Tumor Cells
12/22/2011	US20110311543 Tumor Antigens BFA5 for Prevention and/or Treatment of Cancer
12/22/2011	US20110311541 Mutant proteins of the f protein of piv-5 and piv-2
12/22/2011	US20110311539 Diagnosis and treatment of cancer using cancer-testis antigens
12/22/2011	US20110311536 Prevention of type 1 diabetes by treg vaccination with an insulin mimetope
12/22/2011	US20110311535 Nkg2d-fc for immunotherapy
12/22/2011	US20110311532 Inhibition of complement and cellular activation
12/22/2011	US20110311531 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/22/2011	US20110311530 Truncated baff receptors
12/22/2011	US20110311522 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof
12/22/2011	US20110311518 Novel synthetic agonists of tlr9
12/22/2011	US20110311517 Antibodies and methods for treating estrogen receptor-associated diseases
12/22/2011	US20110311507 Methods for Diagnosing and Treating Autoimmune Disorders
12/22/2011	US20110311485 1,2,4-oxadiazole derivatives and their therapeutic use
12/22/2011	US20110311483 Crth2 modulators
12/22/2011	US20110311482 Hepatitis C Virus Inhibitors
12/22/2011	US20110311479 Modulators of indoleamine 2,3-dioxygenase and methods of using the same
12/22/2011	US20110311475 Means and method for the treatment of antibody deficiency diseases based on il-21 and il-21 variants
12/22/2011	US20110311474 Novel Tricyclic Compounds
12/22/2011	US20110311472 Application of mrna for use as a therapeutic against tumour diseases
12/22/2011	US20110311466 Novel 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
12/22/2011	US20110311454 Molecules with extended half-lives, compositions and uses thereof
12/22/2011	US20110311451 Synthesis of polymer conjugates of indolocarbazole compounds
12/22/2011	US20110311449 Antibodies
12/22/2011	CA2802873A1 Methods of treatment using tlr7 and/or tlr9 inhibitors
12/22/2011	CA2798150A1 New cathepsin s protease inhibitors, useful in the treatment of e.g. autoimmune disorders, allergy and chronic pain conditions
12/22/2011	CA2794731A1 Anti-axl antibodies and methods of use
12/21/2011	EP2397553A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof
12/21/2011	EP2397552A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof
12/21/2011	EP2397499A2 Human anti-B7RP1 neutralizing antibodies
12/21/2011	EP2397498A2 Human anti-B7RP1 neutralizing antibodies
12/21/2011	EP2397497A2 Human anti-B7RP1 neutralizing antibodies
12/21/2011	EP2397496A2 Human anti-B7RP1 neutralizing antibodies

1 ... 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 ... 1172